Merck
MRK
#48
Rank
NZ$557.83 B
Marketcap
NZ$225.86
Share price
0.45%
Change (1 day)
61.73%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): NZ$6.00

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$6.16. In 2025 the company made an earnings per share (EPS) of NZ$12.60 an increase over its 2024 EPS that were of NZ$11.65.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.00-52.37%
2025NZ$12.608.15%
2024NZ$11.654308.46%
2023NZ$0.26-97.32%
2022NZ$9.8710.92%
2021NZ$8.9084.68%
2020NZ$4.82-27.2%
2019NZ$6.6263.44%
2018NZ$4.05151.11%
2017NZ$1.61-54.58%
2016NZ$3.5530.21%
2015NZ$2.73-61.99%
2014NZ$7.17180.51%
2013NZ$2.56-31.82%
2012NZ$3.756.62%
2011NZ$3.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.05 144.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.10 96.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.26-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.22 0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$48.64 689.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.95 305.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.41-28.40%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$6.13-0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.70 8.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.36-61.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel